Peter A. Daly

6.9k total citations
71 papers, 1.9k citations indexed

About

Peter A. Daly is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Peter A. Daly has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 16 papers in Genetics. Recurrent topics in Peter A. Daly's work include BRCA gene mutations in cancer (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (6 papers). Peter A. Daly is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (6 papers). Peter A. Daly collaborates with scholars based in Ireland, United Kingdom and United States. Peter A. Daly's co-authors include W. Ormiston, Emer O. Hanrahan, Bryan T. Hennessy, Ross McManus, Deborah Ford, Richard Wooster, D. S. O’Briain, Lisa Cannon‐Albright, Douglas F. Easton and David E. Goldgar and has published in prestigious journals such as JAMA, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Peter A. Daly

70 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Daly Ireland 19 727 575 489 483 296 71 1.9k
João L. Ascensão United States 21 377 0.5× 529 0.9× 334 0.7× 295 0.6× 599 2.0× 65 1.8k
Lilian Reich United States 25 131 0.2× 585 1.0× 387 0.8× 198 0.4× 1.3k 4.4× 50 2.2k
GL Phillips Canada 25 187 0.3× 1.1k 1.9× 540 1.1× 532 1.1× 1.8k 6.0× 56 3.0k
J H Donohue United States 20 568 0.8× 1.0k 1.8× 226 0.5× 538 1.1× 26 0.1× 41 2.4k
H. Poliwoda Germany 23 126 0.2× 660 1.1× 332 0.7× 151 0.3× 344 1.2× 139 1.8k
H Rubie France 28 154 0.2× 649 1.1× 537 1.1× 590 1.2× 397 1.3× 75 2.3k
Irena Sniecinski United States 22 138 0.2× 510 0.9× 161 0.3× 339 0.7× 1.1k 3.6× 49 1.8k
Pietro Muretto Italy 27 138 0.2× 634 1.1× 528 1.1× 222 0.5× 1.1k 3.8× 77 2.8k
Cheng‐Hwai Tzeng Taiwan 24 145 0.2× 485 0.8× 340 0.7× 141 0.3× 284 1.0× 90 1.3k
Iuliana Shapira United States 20 123 0.2× 787 1.4× 244 0.5× 107 0.2× 133 0.4× 53 1.6k

Countries citing papers authored by Peter A. Daly

Since Specialization
Citations

This map shows the geographic impact of Peter A. Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Daly more than expected).

Fields of papers citing papers by Peter A. Daly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Daly. The network helps show where Peter A. Daly may publish in the future.

Co-authorship network of co-authors of Peter A. Daly

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Daly. A scholar is included among the top collaborators of Peter A. Daly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Daly. Peter A. Daly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrell, Michael, David J. Hughes, Ian Berry, et al.. (2012). Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome. Familial Cancer. 11(3). 509–518. 3 indexed citations
2.
Toner, Mary, et al.. (2012). Focal seizures secondary to cortical dysplasia associated with isolated oral morphea and odontogenic carcinoma. Seizure. 22(2). 159–161. 4 indexed citations
3.
Carroll, Paul, R. N. Clarke, Michael Farrell, et al.. (2011). Surgical management of an Irish cohort of BRCA-mutation carriers. The Breast. 20(5). 419–423. 4 indexed citations
4.
Balfe, Paul, et al.. (2008). Management of gastric lymphoma. The Surgeon. 6(5). 262–265. 3 indexed citations
5.
McVey, G., et al.. (2008). Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: A report of two cases. Acta Oncologica. 47(8). 1590–1593. 15 indexed citations
6.
Hennessy, Bryan T., Emer O. Hanrahan, & Peter A. Daly. (2004). Non-Hodgkin lymphoma: an update. The Lancet Oncology. 5(6). 341–353. 147 indexed citations
7.
Daly, Peter A.. (2004). Hereditary cancer: guidelines in clinical practice—general overview. Annals of Oncology. 15. iv121–iv125. 5 indexed citations
8.
Daly, Peter A., Andrew Green, W. Ormiston, et al.. (2003). Predictive testing for BRCA1 and 2 mutations: a male contribution. Annals of Oncology. 14(4). 549–553. 32 indexed citations
9.
Boyle, Peter, et al.. (2003). Cancer mortality in Ireland, 1926–1995. Annals of Oncology. 14(2). 323–332. 4 indexed citations
10.
Hennessy, Bryan T., John A. McCaffrey, Peter A. Daly, Paul Browne, & Michael J. Kennedy. (2002). High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy. Irish Journal of Medical Science (1971 -). 171(3). 158–160. 1 indexed citations
11.
Stratton, J. F., Deborah J. Thompson, Lynda G. Bobrow, et al.. (1999). The Genetic Epidemiology of Early-Onset Epithelial Ovarian Cancer: A Population-Based Study. The American Journal of Human Genetics. 65(6). 1725–1732. 58 indexed citations
12.
Murphy, Jennifer, Peter A. Daly, & Graham Wilson. (1999). Endorectal ultrasound in a small cell carcinoma of the rectum; staging and assessment of response to chemotherapy. Clinical Radiology. 54(10). 696–698. 2 indexed citations
13.
McDermott, Michael B., et al.. (1995). Malignant lymphoma of the epididymis. A case report of bilateral involvement by a follicular large cell lymphoma. Cancer. 75(8). 2174–2179. 20 indexed citations
14.
Stratton, Michael R., Deborah Ford, Sheila Seal, et al.. (1994). Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genetics. 7(1). 103–107. 107 indexed citations
15.
16.
Maher, John, Paul Browne, Leslie Daly, Shaun R. McCann, & Peter A. Daly. (1993). A circadian distribution to febrile episodes in neutropenic patients. Supportive Care in Cancer. 1(2). 98–100. 4 indexed citations
17.
O’Riordan, Thomas G., et al.. (1990). Progressive multifocal leukoencephalopathy-remission with cytarabine. Journal of Infection. 20(1). 51–54. 47 indexed citations
18.
O’Riordan, Thomas G., Eoin F. Gaffney, Vincent Tormey, & Peter A. Daly. (1990). Hyperamylasemia associated with progression of a serous surface papillary carcinoma. Gynecologic Oncology. 36(3). 432–434. 6 indexed citations
19.
McQuaid, Shirley, Shaun R. McCann, Peter A. Daly, Emer Lawlor, & Peter Humphries. (1989). Observations on the transcriptional activity of the glutathione S-transferase π gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy. British Journal of Cancer. 59(4). 540–543. 12 indexed citations
20.
Graeme‐Cook, Fiona, D. S. O’Briain, & Peter A. Daly. (1988). Unusual Breast Masses. The sequential development of mammary tuberculosis and Hodgkin's disease in a young woman. Cancer. 61(7). 1457–1459. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by João L. Ascensão Breakdown of academic impact, for papers by Lilian Reich Breakdown of academic impact, for papers by GL Phillips Breakdown of academic impact, for papers by J H Donohue Breakdown of academic impact, for papers by H. Poliwoda Breakdown of academic impact, for papers by H Rubie Breakdown of academic impact, for papers by Irena Sniecinski Breakdown of academic impact, for papers by Pietro Muretto Breakdown of academic impact, for papers by Cheng‐Hwai Tzeng Breakdown of academic impact, for papers by Iuliana Shapira
Rankless by CCL
2026